TRIANGEL spotlights aesthetic laser systems at Dubai Derma

TRIANGEL used Dubai Derma in Dubai to pitch its aesthetic laser portfolio to Middle East clinics and distributors as demand rises for non-surgical facial lifting and tissue remodeling. The company highlighted FDA and CE-cleared platforms, multi-year clinical durability, and regional distribution support for Gulf medical beauty providers.

Why it matters: - The Middle East aesthetic market is expanding around non-surgical face lifting and tissue remodeling. - Clinics and private surgical hospitals across the Gulf are looking for treatments that deliver tightening with shorter recovery times. - TRIANGEL is targeting that demand with laser platforms positioned for facial contouring, body contouring, and skin rejuvenation.

What happened: - TRIANGEL presented its aesthetic laser portfolio at the Dubai World Dermatology and Laser Conference and Exhibition, known as Dubai Derma. - The company used the event to court dermatologists, clinic owners, and medical equipment distributors from across the Middle East. - TRIANGEL also invited attendees to request technical specifications, clinical protocol documentation, and factory quotations through its medical engineering portal: More information.

The details: - TRIANGEL was founded in 2013 and operates under ISO 13485 standards. - The company says its platforms hold FDA clearance and Medical CE certification. - The TR-B series endolaser workstation combines 980 nm and 1470 nm diode emission for minimally invasive facial contouring. - The system uses single-use micro-optical fibers measuring 200 to 600 micrometers. - The 1470 nm wavelength targets water inside subdermal adipocytes. - The 980 nm diode module coagulates small vascular branches during treatment. - The company describes the thermal working range as 50 to 65 degrees Celsius in the superficial musculoaponeurotic system. - TRIANGEL says the TR-B platform supports body contouring in the abdomen, inner thighs, gluteal region, and knees. - TRIANGEL also showed the ENDO PRO platform, which combines interstitial lasers with 4 MHz fractional radiofrequency microneedling. - The ENDO PRO system offers motorized depth control from 0.5 to 7 millimeters. - The RegenOS 4-wavelength tissue regeneration console was also part of the showcase. - TRIANGEL says the combined portfolio can address skin laxity, enlarged pores, acne scars, and facial definition. - The company says its platforms support skin types III through VI through subdermal energy delivery that bypasses the epidermis. - TRIANGEL says its systems are registered under UKCA in the United Kingdom and ANVISA in Brazil. - The TR-B series is audited by BSI 2797 under Medical CE MDR certification. - TRIANGEL says its quality framework is overseen by 12 quality inspection specialists. - The company says long-term follow-up shows sustained aesthetic outcomes for up to 4 years after a single procedure. - TRIANGEL cites more than 15,000 successful procedures globally, research collaborations with 15 partner hospitals and four European clinical research centers, more than 12,000 installations in 80-plus countries, and more than 300 physician endorsements.

Between the lines: - TRIANGEL is framing regulatory clearances, training, and logistics as part of the product, not just the device. - The regional pitch is aimed at clinics that want predictable outcomes, localized support, and faster access to consumables and replacement parts. - The company is also trying to differentiate on skin-tone safety, a key issue in Gulf markets with higher Fitzpatrick phototypes.

What's next: - TRIANGEL is expanding its distribution push across the United Arab Emirates, Saudi Arabia, Qatar, and Kuwait. - The company says regional partners will get localized interfaces, private-label branding, marketing materials, and clinical training support. - TRIANGEL says it can deliver sterile optical fibers, cannulas, and replacement parts worldwide within two weeks. - The company is directing potential partners to its global service network, which includes two US clinical training centers and European branch offices.